NCT02143596

Brief Summary

The investigators studied laboratory measurements and previously identified risk factors to identify factors predictors of early deterioration following stroke. A prospective observational study of 196 patients with first-time acute ischemic stroke was performed. Following multivariate analysis, only a Bun/Cr \>15 was independent predictor of SIE. These patients were 3.41-fold more likely to have SIE (P=0.008). The elevated Bun/Cr ratio indicates relative dehydration of the patients. An immediate intervention for such patients should be the maintenance of proper hydration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
159

participants targeted

Target at P75+ for phase_2 stroke

Timeline
Completed

Started Nov 2010

Typical duration for phase_2 stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 21, 2014

Completed
Last Updated

May 26, 2014

Status Verified

May 1, 2014

Enrollment Period

3.1 years

First QC Date

May 19, 2014

Last Update Submit

May 23, 2014

Conditions

Keywords

strokedehydrationprognosis

Outcome Measures

Primary Outcomes (1)

  • rate of stroke in evolution

    72 hours after admission

Study Arms (2)

Bun/Cr based hydration

ACTIVE COMPARATOR

receive intravenous normal saline infusion and adjust infusion rate by Bun/Cr followed in the first 72 hours

Other: normal saline

control

NO INTERVENTION

receive intravenous normal saline infusion as clinician's adjustment

Interventions

the infusion rate of normal saline is determinated by clinicians according to Bun/Cr ratio followed

Bun/Cr based hydration

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • acute stroke

You may not qualify if:

  • the time between the onset of neurological symptoms and emergency department presentation are more than 12 hours
  • required fibrinolytic therapy
  • required surgical intervention
  • underline disease including congestive heart failure, chronic renal failure ( Cr\>2 mg/dl) , liver cirrhosis, chronic obstructive pulmonary disease
  • \. initial systolic blood pressure\>200 or diastolic blood pressure \> 120 mmHg
  • initial systolic blood pressure\<100 mmHg
  • oxygen saturation less than 92% ( room air )
  • \. require diuretics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Chiayi City, 613, Taiwan

Location

Related Publications (2)

  • Lin LC, Yang JT, Weng HH, Hsiao CT, Lai SL, Fann WC. Predictors of early clinical deterioration after acute ischemic stroke. Am J Emerg Med. 2011 Jul;29(6):577-81. doi: 10.1016/j.ajem.2009.12.019. Epub 2010 Apr 2.

    PMID: 20825831BACKGROUND
  • Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M. Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke. 2000 Sep;31(9):2049-54. doi: 10.1161/01.str.31.9.2049.

    PMID: 10978028BACKGROUND

MeSH Terms

Conditions

StrokeDehydration

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesWater-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Leng C Lin, M.D.

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2014

First Posted

May 21, 2014

Study Start

November 1, 2010

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

May 26, 2014

Record last verified: 2014-05

Locations